Risk Scores for Hepatocellular Carcinoma in Chronic Hepatitis B: A Promise for Precision Medicine

Hepatology. 2020 Dec;72(6):2197-2205. doi: 10.1002/hep.31440. Epub 2020 Nov 13.

Authors

George V Papatheodoridis¹, Thodoris Voulgaris¹, Margarita Papatheodoridi¹, W Ray Kim²

Affiliations

¹ Department of Gastroenterology, Medical School of National and Kapodistrian University of Athens, General Hospital of Athens "Laiko", Athens, Greeces.
² Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA.

PMID: 32602980
DOI: 10.1002/hep.31440

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Antiviral Agents / therapeutic use
Carcinoma, Hepatocellular / epidemiology*
Carcinoma, Hepatocellular / pathology
Carcinoma, Hepatocellular / prevention & control
Carcinoma, Hepatocellular / virology
Hepatitis B, Chronic / drug therapy
Hepatitis B, Chronic / pathology*
Hepatitis B, Chronic / virology
Humans
Incidence
Liver Neoplasms / epidemiology*
Liver Neoplasms / pathology
Liver Neoplasms / prevention & control
Liver Neoplasms / virology
Predictive Value of Tests
Risk Assessment / methods*
Risk Factors

Substances

Antiviral Agents